SPECIAL REPORT

Healthy Horizons
A brand new series of weekly segments which will explore the macro and micro issues facing the global economy.

LATEST FROM OUR BLOGS

» More

- Why You Should Play the Reflation Trade: Stock Picker

MORE HEADLINES

» Markets | Economy | Companies

- Half of Banks' Losses May Still Be Hidden: IMF Head

PHARMA'S MARKET VIDEO

» More

Sebelius on Vaccines

24 Nov 2009

Discussing whether a new $487M investment from the government will help speed up the production of the most important vaccines, with Kathy Sebelius, Health & Human Services secretary and CNBC's Mike Huckman.

The New Formula for Faster Vaccines

24 Nov 2009

Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.

Novartis Opens 1st US Plant for Flu Vaccine

24 Nov 2009

Cholesterol Drug Battle: Niaspan vs. Zetia 16 Nov 2009
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.

Cardiologist Grades Cholesterol Drug Study

16 Nov 2009

Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr. Steven Nissen, chairman of the Department of Cardiovascular Medicine at The Cleveland Clinic, shares his reaction with CNBC's Mike Huckman.

Merck's Cholesterol Drugs Under Pressure

16 Nov 2009

A new study is putting Merck's cholesterol drugs under pressure today, reports CNBC's Mike Huckman, with Ken Frazier, Merck Global Human Health president.

RSS FEED

» Help

Subscribe to this RSS feed
Stay up to date with Pharma's Market.

CNBC ON DIGG

Pharma's Market

Text Size

Dec.02

4:27 PM ET

Tuesday, 2 Dec 2008

Sam Waksal: "Moving On Up" To The East Side

Posted By:Mike Huckman

Topics:Pharmaceuticals

Sectors:Health Care Equipment and Services | Health Care | Pharmaceuticals

Companies:Eli Lilly and Company

Sam Waksal
AP
Sam Waksal, former CEO of ImClone Systems

As the folks at biotechnology firm ImClone Systems are getting used to their first week of life inside big pharma--Eli Lilly [LLY Loading... () ] , Sam Waksal is getting used to life on the outside.

CNBC assignment desk guru Jim Forkin was bird-dogging the Federal Bureau of Prisons web site--he apparently does that from time to time to try to keep tabs on all of the imprisoned corporate rogues--when he came across that the 61-year-old ImClone founder Waksal's page showing that he's now in Brooklyn. Four months ago I blogged that the 61-year-old ImClone founder had left a Michigan prison for a halfway house in the Bronx.

Well, he didn't stay there for long. When Forkin called the new Brooklyn address to my attention we assumed he'd been transferred. But a BOP spokesperson tells Forkin that Waksal actually left the Bronx joint back in early September and since then has been under home confinement. The Brooklyn address is on the BOP web site because that's the office where Waksal has to periodically check in with authorities. A source close to Waksal tells me he's living on Manhattan's upper east side. The BOP spokesperson also tells Forkin that Waksal's got a job. I don't know where he's working.

Waksal got into trouble for insider trading at ImClone. It's the scandal that also ensnared his old friend Martha Stewart who had to serve months in prison. Waksal had to do years. His sentence doesn't end until early next February, so he's technically under home confinement until then. And Sam, if you happen to read this, you still have an open invitation to do an interview. We could come to you, so you wouldn't have to get permission from the BOP to leave your apartment...er, townhouse?

Questions? Comments?

Tools:

Print Email